These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22692671)

  • 1. Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.
    Guo Z; Chen A; Nassar RA; Helk B; Mueller C; Tang Y; Gupta K; Klibanov AM
    Pharm Res; 2012 Nov; 29(11):3102-9. PubMed ID: 22692671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.
    Liu J; Nguyen MD; Andya JD; Shire SJ
    J Pharm Sci; 2005 Sep; 94(9):1928-40. PubMed ID: 16052543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic salts markedly diminish viscosity of concentrated protein solutions.
    Du W; Klibanov AM
    Biotechnol Bioeng; 2011 Mar; 108(3):632-6. PubMed ID: 21246510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.
    Binabaji E; Ma J; Zydney AL
    Pharm Res; 2015 Sep; 32(9):3102-9. PubMed ID: 25832501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions.
    Ke P; Batalha IL; Dobson A; Tejeda-Montes E; Ekizoglou S; Christie G; McCabe J; van der Walle CF
    Int J Pharm; 2018 Sep; 548(1):682-688. PubMed ID: 30009985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies.
    Larson AM; Weight AK; Love K; Bonificio A; Wescott CR; Klibanov AM
    J Pharm Sci; 2017 May; 106(5):1211-1217. PubMed ID: 28137697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viscosity-Reducing Bulky-Salt Excipients Prevent Gelation of Protein, but Not Carbohydrate, Solutions.
    Kumar A; Klibanov AM
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1491-1496. PubMed ID: 28116573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions.
    Srinivasan C; Weight AK; Bussemer T; Klibanov AM
    Pharm Res; 2013 Jul; 30(7):1749-57. PubMed ID: 23543302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.
    Majumder S; Bhattacharya DS; Langford A; Ignatius AA
    Pharm Res; 2022 Mar; 39(3):529-539. PubMed ID: 35174433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions.
    Prašnikar M; Proj M; Bjelošević Žiberna M; Lebar B; Knez B; Kržišnik N; Roškar R; Gobec S; Grabnar I; Žula A; Ahlin Grabnar P
    Int J Pharm; 2024 Apr; 655():124055. PubMed ID: 38554741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly lowering the viscosity of aqueous solutions of DNA by additives.
    Elkin I; Weight AK; Klibanov AM
    Int J Pharm; 2015 Oct; 494(1):66-72. PubMed ID: 26260229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions.
    Wei Y; Qi W; Maglalang E; Pelegri-O'Day EM; Luong M; Razinkov V; Sloey C
    Mol Pharm; 2023 Dec; 20(12):6420-6428. PubMed ID: 37906640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing monoclonal antibody formulations in arginine glutamate solutions using
    Kheddo P; Cliff MJ; Uddin S; van der Walle CF; Golovanov AP
    MAbs; 2016 Oct; 8(7):1245-1258. PubMed ID: 27589351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.
    Yadav S; Shire SJ; Kalonia DS
    J Pharm Sci; 2010 Dec; 99(12):4812-29. PubMed ID: 20821382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cations and anions on glass transition temperatures in excipient solutions.
    Nesarikar VV; Nassar MN
    Pharm Dev Technol; 2007; 12(3):259-64. PubMed ID: 17613889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2.
    Hu Y; Toth RT; Joshi SB; Esfandiary R; Middaugh CR; Volkin DB; Weis DD
    J Pharm Sci; 2020 Jan; 109(1):353-363. PubMed ID: 31195015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration Effects in the Interaction of Monoclonal Antibodies (mAbs) with their Immediate Environment Characterized by EPR Spectroscopy.
    Haeri HH; Blaffert J; Schöffmann FA; Blech M; Hartl J; Garidel P; Hinderberger D
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.
    Hung JJ; Dear BJ; Dinin AK; Borwankar AU; Mehta SK; Truskett TT; Johnston KP
    Pharm Res; 2018 Apr; 35(7):133. PubMed ID: 29713822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.